Author

I. Del Priore

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Assay:organoid / primary culture· 1

Frequent Co-Authors

A. Bhutkar· 1 shared A. Chaves-Perez· 1 shared A. Ghosh· 1 shared A. N. Wuest· 1 shared A. Zhang· 1 shared B. Meskauskaite· 1 shared C. A. Iacobuzio-Donahue· 1 shared C. M. Cabana· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Bhutkar

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Chromosome 9p21.3 Coordinates Cell Intrinsic and Extrinsic Tumor Suppression

S. Lowe, F. M. Barriga, K. M. Tsanov, Y. J. Ho, N. Sohail, A. Zhang, T. Baslan, A. N. Wuest, I. Del Priore, B. Meskauskaite, G. Livshits, D. Alonso-Curbelo, J. Simon, A. Chaves-Perez, D. Bar-Sagi, , D. Pe'er

The paper investigates how 9p21.3 deletions in cancer disable both cell intrinsic and extrinsic tumor suppression by co-deleting CDKN2A/B and type I interferons, leading to immune evasion and metastasis.

bioRxiv · Aug 22, 2022 · PreprintCancer Biology

Modeling diverse genetic subtypes of lung adenocarcinoma with a next-generation alveolar type 2 organoid platform

S. Naranjo, C. M. Cabana, L. M. LaFave, P. M. Westcott, R. Romero, A. Ghosh, L. Z. Liao, J. M. Schenkel, I. Del Priore, A. Bhutkar, D. Yang, T. Jacks

This study develops a reliable alveolar type 2 organoid platform to model diverse genetic subtypes of lung adenocarcinoma in vitro and in vivo.

bioRxiv · Dec 7, 2021 · PreprintCancer Biology